Microfluidics to Address Pandemics - SARS-CoV-2 and Beyond

Overview

The SARS-CoV-2 Coronavirus Pandemic is evolving and the various variants which currently are driving the pandemic forward are responsible for morbidity, mortality and economic strains globally.

This 2-day conference held onsite as a regular physical conference at the Hilton Rotterdam, The Netherlands takes a deep dive on the current role of Microfluidics Technologies in SARS-CoV-2 testing (circa 2022) and expectations for the future role of Microfluidics in the Management of Pandemics.

The conference brings together companies engaged in this space from the larger diagnostics companies to the emerging companies providing technical solutions in this field -- Providing them a platform to present their technology/offering to the community and engage.

In addition to presentations, there will be posters to highlight technologies and late-breaking developments.

This conference is chaired by Dr. Holger Becker, Chief Scientific Officer and Co-Founder of microfluidic ChipShop GmbH and a key opinion leader in the microfluidics and lab-on-a-chip field.